BCMA/CD70-targetd CAR-T
PBC103
Phase 1 mab active
Quick answer
BCMA/CD70-targetd CAR-T for Juvenile Dermatomyositis (JDM) is a Phase 1 program (mab) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PRECISION BIOSCIENCES INC
- Indication
- Juvenile Dermatomyositis (JDM)
- Phase
- Phase 1
- Modality
- mab
- Status
- active